Aaron Berg

Mr. Berg has over 25 years of life science industry experience and joined Amarin in November 2012 as vice president, marketing and managed care. He was promoted to senior vice president, marketing and sales in February 2014, and to the position of senior vice president and chief commercial officer in April 2018. Before joining Amarin, Mr. Berg served as president and chief executive officer for Essentialis, Inc., a development stage pharmaceutical company where he led the company's work on triglyceride management. Prior to joining Essentialis, Mr. Berg served as vice president of marketing and sales at Kos Pharmaceuticals, where he was instrumental in driving annual revenues approaching $1 billion and was there until the acquisition of the company by Abbott Laboratories in December 2006 for $3.7 billion. Mr. Berg began his pharmaceutical industry career as a sales representative with Bristol-Myers Squibb, followed by various commercial positions with Schering-Plough and GlaxoSmithKline.